All In Biotech

Drug Trial Radar · NCT02554786

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma

Last checked: Nov 19, 2026Latest source record: Mar 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,216 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,216

Actual

Start

Dec 29, 2015

Primary completion

Nov 21, 2018

Study completion Jun 28, 2019

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Sep 18, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to evaluate the efficacy and safety of two different doses of QMF149 (QMF149 150/160 µg and QMF149 150/320 µg via Concept1) over two respective MF doses (MF 400 µg and MF 800 µg via Twisthaler® (total daily dose)) in poorly controlled asthmatic participants as determined by pulmonary function testing, and effects on asthma control

Conditions

  • Asthma

Interventions

  • Indacaterol acetate/Mometasone furoateDrug

  • Mometasone furoateDrug

  • Salmeterol xinafoate/fluticasone propionateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Trough Forced Expiratory Volume in One Second (Trough FEV1) at Week 26Time frame: 26 weeks

Locations

388 sites in 24 countries. Site status is shown where the registry gives one.

  • Novartis Investigative Site

    Birmingham, Alabama

  • Novartis Investigative Site

    Los Angeles, California

  • Novartis Investigative Site

    Orange, California

  • Novartis Investigative Site

    Riverside, California

  • Novartis Investigative Site

    San Diego, California

  • Novartis Investigative Site

    San Jose, California

  • Novartis Investigative Site

    Stockton, California

  • Novartis Investigative Site

    Westminster, California

  • Novartis Investigative Site

    Denver, Colorado

  • Novartis Investigative Site

    Miami, Florida

  • Novartis Investigative Site

    Tallahassee, Florida

  • Novartis Investigative Site

    Winter Park, Florida

  • Novartis Investigative Site

    Baltimore, Maryland

  • Novartis Investigative Site

    Waldorf, Maryland

  • Novartis Investigative Site

    North Dartmouth, Massachusetts

  • Novartis Investigative Site

    St Louis, Missouri

  • Novartis Investigative Site

    Bellevue, Nebraska

  • Novartis Investigative Site

    Las Vegas, Nevada

  • Novartis Investigative Site

    Skillman, New Jersey

  • Novartis Investigative Site

    Cortland, New York

  • Novartis Investigative Site

    Oklahoma City, Oklahoma

  • Novartis Investigative Site

    Tulsa, Oklahoma

  • Novartis Investigative Site

    Medford, Oregon

  • Novartis Investigative Site

    Portland, Oregon

  • Novartis Investigative Site

    Pittsburgh, Pennsylvania

  • Novartis Investigative Site

    North Charleston, South Carolina

  • Novartis Investigative Site

    Boerne, Texas

  • Novartis Investigative Site

    El Paso, Texas

  • Novartis Investigative Site

    Greenfield, Wisconsin

  • Novartis Investigative Site

    Pleven, Bulgaria

  • Novartis Investigative Site

    Plovdiv, Bulgaria

  • Novartis Investigative Site

    Rousse, Bulgaria

  • Novartis Investigative Site

    Sofia, Bulgaria

  • Novartis Investigative Site

    Sofia, Bulgaria

  • Novartis Investigative Site

    Sofia, Bulgaria

  • Novartis Investigative Site

    Stara Zagora, Bulgaria

  • Novartis Investigative Site

    Troyan Municipality, Bulgaria

  • Novartis Investigative Site

    Plovdiv, BGR, Bulgaria

  • Novartis Investigative Site

    Varna, BGR, Bulgaria

  • Novartis Investigative Site

    Vidin, BGR, Bulgaria

Showing 40 of 388 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.